Bisphosphonates (BP) have been commonly used over the past 40 years to treat osteoporosis, Pagets' disease, hypercalcemia of malignancy, osteolytic lesions of multiple myeloma and bone metastases associated with breast, prostate, lung and other soft tissue tumours.
Background: Bisphosphonates (BP) have been commonly used over the past 40 years to treat osteoporosis, Pagets' disease, hypercalcemia of malignancy, osteolytic lesions of multiple myeloma and bone metastases associated with breast, prostate, lung and other soft tissue tumours. With an increasing proportion of the population being prescribed oral bisphosphonates, in particular, it is inevitable that some of these patients may require or request implant therapy. Therefore the effects that these drugs may have on implant survival and success is very important.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.